Effects of recombinant human granulocyte colony-stimulating factor on neutrophil function in normal rats

Int J Hematol. 1991 Dec;54(6):455-62.

Abstract

We studied the effects of recombinant human granulocyte colony-stimulating factor (rG-CSF) on neutrophil functions in vitro using neutrophils isolated from the venous blood of normal rats. FMLP-induced superoxide anion (O2-) release, phagocytosis, and FMLP-induced chemotaxis were evaluated. These functions were significantly enhanced by rG-CSF treatment. In addition to performing neutrophil function assays, we evaluated FMLP binding to rat neutrophils after rG-CSF treatment. FMLP specific binding was not changed by rG-CSF treatment. In addition, we intravenously injected rG-CSF (10 micrograms/kg) or control vehicle into rats for 7 consecutive days, and evaluated the functions of neutrophils isolated from venous blood at 6 h after the final injection. The neutrophil count in the peripheral blood of rG-CSF-treated rats was increased significantly compared with that in control rats. FMLP-induced O2- release, phagocytosis, FMLP-induced chemotaxis and spontaneous migration of rG-CSF-treated neutrophils were significantly enhanced in comparison with those in control rats. These findings demonstrate that rG-CSF not only increases neutrophil counts in peripheral blood, but that it also enhances neutrophil functions, both in vitro and in vivo.

MeSH terms

  • Animals
  • Granulocyte Colony-Stimulating Factor / pharmacology*
  • Humans
  • In Vitro Techniques
  • Male
  • Neutrophils / drug effects*
  • Neutrophils / physiology
  • Rats
  • Rats, Inbred Strains
  • Recombinant Proteins / pharmacology
  • Reference Values

Substances

  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor